Фармакогенетический и биоинженерный подходы к лечению глиальных опухолей головного мозга
И. С. Брюховецкий, А. С. Брюховецкий, Ю. С. Хотимченко · Genes and Cells · 2014
Cited by 0 works.
Authors
References
- I nternational S ociety of N europathology‐ H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
- Glioblastoma and Other Malignant Gliomas
- Tumour heterogeneity and cancer cell plasticity
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- MGMT testing—the challenges for biomarker-based glioma treatment
- Cell fusion causes confusion
- Combined analysis of TERT , EGFR , and IDH status defines distinct prognostic glioblastoma classes
- Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
- Hypoxia-Inducible Factors as Essential Regulators of Inflammation